Reckitt Benckiser agreed to pay 400 million to state governments to resolve litigation involving improper marketing of the opioid addiction treatment drug Suboxone. This was part of a larger 1.3 billion criminal and civil settlement also involving the federal government; ###-reckitt-benckiser-group-plc-0